This article discusses litigation over the new rule as well as the rule’s changes to prohibit the coverage of treatment for ...

Recently, the Second Circuit, Sixth Circuit, and a Texas district again rejected the pharmaceutical industry’s challenges to ...

Health Affairs' Rob Lott interviews Steven M. Lieberman of the University of Southern California, Los Angeles on his recent ...

Additional deregulatory action is assured across a wide range of agencies, especially as the administration is reportedly ...

By focusing on three priorities—one corresponding to each goal—the Center for Medicare and Medicaid Innovation’s leaders can ...

Health Affairs' Jeff Byers welcomes Senior Editor Kathleen Haddad back to the pod to take a look at recent news that HHS ...

As transformative as they may be for patients, cell and gene therapies are creating new kinds of uncertainty and challenges ...

One way to save Medicaid money while ensuring that funds are spent to improve staffing and services is to substantially ...

By combining the ETHIC bill and a legislative formulation of a withdrawn USPTO rule, Congress has an opportunity to enact ...

Reducing the rates at which mothers and infants die and eliminating inequities in survival are possible only when a strategic ...

This particular case concerns access to COVID vaccinations for two vulnerable groups, pregnant women and children, but more ...

Creating clear regulatory frameworks and reimbursement standards can help ensure the responsible and effective integration of AI to improve the health of older adults.